MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.exer.2026.111291

Медицинская библиотека · Experimental eye research · 2026

Hepatocyte Growth Factor Alleviates Dry Eye Disease by Modulating the HMGB1/TLR4 Signaling Pathway: Potential Mechanisms and Therapeutic Implications.

Song Benhao, Liang Yihao, Jiang Zipei, Dong Haishu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Dry eye disease (DED) is a prevalent ocular surface disorder involving persistent inflammatory responses, redox imbalance, and impairment of corneal epithelial integrity. Despite the recognized regenerative and immunomodulatory functions of hepatocyte growth factor (HGF), whether HGF contributes to the maintenance of ocular surface homeostasis during DED progression and the mechanisms involved remain largely undefined.

METHODS

A hyperosmolar stress-induced HCEC injury model and a mouse model of experimental DED were established to evaluate the protective effects of HGF. Cell viability, inflammatory responses, oxidative stress, and apoptosis were assessed using CCK-8, ELISA, qRT-PCR, Western blotting, DCFH-DA staining, and flow cytometry. Corneal fluorescein staining and Schirmer tests were performed to evaluate ocular surface damage in mice. The involvement of the HMGB1/TLR4 pathway was investigated through molecular analyses and HMGB1 knockdown experiments.

RESULTS

HGF significantly alleviated hyperosmolarity-induced HCEC injury by enhancing cell viability, reducing ROS accumulation and apoptosis, and suppressing pro-inflammatory cytokine production. In DED mice, HGF treatment improved corneal epithelial defects, increased tear secretion, and reduced ocular surface inflammation. Mechanistically, HGF inhibited HMGB1/TLR4 signaling activation, while HMGB1 silencing mimicked the protective effects of HGF.

CONCLUSIONS

HGF protects against DED-associated corneal epithelial injury by suppressing HMGB1/TLR4-mediated inflammatory responses, suggesting its potential as a therapeutic target for DED.

Для цитирования: Song Benhao, Liang Yihao, Jiang Zipei, Dong Haishu. Hepatocyte Growth Factor Alleviates Dry Eye Disease by Modulating the HMGB1/TLR4 Signaling Pathway: Potential Mechanisms and Therapeutic Implications.. Experimental eye research. 2026. DOI: 10.1016/j.exer.2026.111291.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.